Medical Disposables & Supplies Limited (JMSE:MDS)
Jamaica
· Delayed Price · Currency is JMD 1.320
0.00 (0.00%)
At close: Jun 24, 2025
JMSE:MDS Income Statement
Financials in millions JMD. Fiscal year is April - March.
Millions JMD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 3,884 | 3,709 | 3,770 | 3,416 | 2,423 | Upgrade
| |
Revenue Growth (YoY) | 4.71% | -1.60% | 10.35% | 41.01% | -2.35% | Upgrade
|
Cost of Revenue | 3,008 | 2,995 | 2,756 | 2,480 | 1,824 | Upgrade
|
Gross Profit | 876.43 | 713.9 | 1,014 | 936.46 | 598.89 | Upgrade
|
Selling, General & Admin | 867.35 | 844.35 | 783.5 | 670.14 | 480.17 | Upgrade
|
Other Operating Expenses | -15.96 | -15.99 | -10.1 | -9.27 | -5.22 | Upgrade
|
Operating Expenses | 1,028 | 889.17 | 818 | 714.67 | 504.45 | Upgrade
|
Operating Income | -151.66 | -175.27 | 195.72 | 221.8 | 94.45 | Upgrade
|
Interest Expense | -153.71 | -159.93 | -104.17 | -71.65 | -70.09 | Upgrade
|
Interest & Investment Income | 0.12 | 0.27 | 2.47 | 11.1 | 0.48 | Upgrade
|
Currency Exchange Gain (Loss) | 20.92 | 14.4 | 2.87 | -17.97 | -11.04 | Upgrade
|
EBT Excluding Unusual Items | -284.33 | -320.51 | 96.89 | 143.28 | 13.8 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | -0.17 | 3.18 | 0.05 | Upgrade
|
Other Unusual Items | - | - | - | - | 62.09 | Upgrade
|
Pretax Income | -284.33 | -320.51 | 96.72 | 146.46 | 75.94 | Upgrade
|
Income Tax Expense | -3.27 | -4.55 | 16.52 | 41.03 | 6.32 | Upgrade
|
Earnings From Continuing Operations | -281.06 | -315.96 | 80.2 | 105.43 | 69.61 | Upgrade
|
Minority Interest in Earnings | 79.23 | 23.87 | -8.06 | -8.47 | - | Upgrade
|
Net Income | -201.83 | -292.09 | 72.14 | 96.97 | 69.61 | Upgrade
|
Net Income to Common | -201.83 | -292.09 | 72.14 | 96.97 | 69.61 | Upgrade
|
Net Income Growth | - | - | -25.61% | 39.29% | 101.45% | Upgrade
|
Shares Outstanding (Basic) | 263 | 263 | 263 | 263 | 263 | Upgrade
|
Shares Outstanding (Diluted) | 263 | 263 | 263 | 263 | 263 | Upgrade
|
EPS (Basic) | -0.77 | -1.11 | 0.27 | 0.37 | 0.26 | Upgrade
|
EPS (Diluted) | -0.77 | -1.11 | 0.27 | 0.37 | 0.26 | Upgrade
|
EPS Growth | - | - | -25.61% | 39.29% | 101.45% | Upgrade
|
Free Cash Flow | -52.01 | -91.83 | 10.98 | -161.6 | -20.46 | Upgrade
|
Free Cash Flow Per Share | -0.20 | -0.35 | 0.04 | -0.61 | -0.08 | Upgrade
|
Dividend Per Share | - | - | - | 0.090 | 0.070 | Upgrade
|
Dividend Growth | - | - | - | 28.57% | - | Upgrade
|
Gross Margin | 22.56% | 19.25% | 26.89% | 27.41% | 24.72% | Upgrade
|
Operating Margin | -3.91% | -4.72% | 5.19% | 6.49% | 3.90% | Upgrade
|
Profit Margin | -5.20% | -7.88% | 1.91% | 2.84% | 2.87% | Upgrade
|
Free Cash Flow Margin | -1.34% | -2.48% | 0.29% | -4.73% | -0.84% | Upgrade
|
EBITDA | -113.25 | -136.43 | 233.65 | 258.7 | 120.92 | Upgrade
|
EBITDA Margin | -2.92% | -3.68% | 6.20% | 7.57% | 4.99% | Upgrade
|
D&A For EBITDA | 38.41 | 38.84 | 37.93 | 36.9 | 26.48 | Upgrade
|
EBIT | -151.66 | -175.27 | 195.72 | 221.8 | 94.45 | Upgrade
|
EBIT Margin | -3.91% | -4.72% | 5.19% | 6.49% | 3.90% | Upgrade
|
Effective Tax Rate | - | - | 17.08% | 28.01% | 8.33% | Upgrade
|
Advertising Expenses | 62.36 | 77.39 | 58.18 | 43.12 | 28.32 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.